Want to see BBOT full AI Analyst Report?

BridgeBio Oncology Therapeutics (BBOT) Cash flow

78 Followers

BridgeBio Oncology Therapeutics Cash Flow

BBOT's free cash flow for Q2 2026 was $-44.41M. For the 2026 fiscal year, BBOT's free cash flow was decreased by $-113.74M and operating cash flow was $-44.36M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -113.89M	$ -763.82K	$ -52.08M	$ 0.00	$ 0.00
Investing Cash Flow	$ 73.33M	$ -184.00M	$ -2.82M	$ 0.00	$ 0.00
Financing Cash Flow	$ 383.40M	$ 186.46M	$ 55.12M	$ 0.00	$ 0.00
End Cash Position	$ 373.82M	$ 1.70M	$ 250.00K	$ 0.00	$ 0.00
Free Cash Flow	$ -114.50M	$ -763.82K	$ -52.49M	$ 0.00	$ 0.00

Currency in USD